BioPharm International - May 2024

BioPharm International - May 2024

Issue link: https://www.e-digitaleditions.com/i/1520706

Contents of this Issue

Navigation

Page 17 of 21

18 BioPharm International ® Partnerships for Outsourcing eBook May 2024 www.biopharminternational.com W orking with a contract development and manufacturing organization (CDMO) is a great way for smaller or diversied bio- tech companies, and even Big Pharma, to expand operations or modalities to reach the patients more eciently. Outsourcing process development and manufacturing requires a lesser upfront investment with faster timelines while allowing teams at advanced therapy developers to focus on innovation. However, this relationship can deeply impact the quality and ef- cacy of a product. This article explores the balancing act of ensuring regulatory compliance via internal pro- cedures at a CDMO and what to consider when starting this relationship. Quality in the contract CDMOs w i l l a lways have mu lt iple c ustomers, a s this is how their business model is built. It can be an uncomfortable position to seek a CDMO, particularly for those coming from Big Pharma, where there is direct quality oversight over processes. Looking for a CDMO with a wide platform of tools that can be tailored to meet regulatory compliance and both pro- vider and customer pharmaceutical quality system (PQS) requirements is important. Unfor tunately, many CDMOs of fer qualit y pro- cesses with minimal f lexibilit y for customers be- cause this is the easiest for the CDMO to control. Doi ng t h is m i n i m i zes t he r isk s a ssociated w it h customer specific variations to processes, reduces costs for the CDMO, and is easier to defend during inspections. However, this can lead to a disconnect between the customer and the supplier. When CDMOs develop quality agreements with a greater focus on client needs, it can increase trust, compliance, and even make audits easier to manage. Complex procedures can be simplified by engaging all parties and clearly documenting in the quality Ensuring Quality in Contracted Support Iain McGhee is vice president of Quality at Ascend. This article looks at the relationship between a CDMO quality organization and the client. J BETTENCOURT/PEOPLEIMAGES.COM - STOCK.ADOBE.COM

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - May 2024 - BioPharm International - May 2024